Revance Therapeutics Inc (RVNC)
2.345
-0.22
(-8.40%)
USD |
NASDAQ |
Jun 25, 16:00
2.345
0.00 (0.00%)
After-Hours: 19:04
Revance Therapeutics Net Income (Annual): -323.99M for Dec. 31, 2023
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | -323.99M |
| December 31, 2022 | -356.42M |
| December 31, 2021 | -281.31M |
| December 31, 2020 | -282.09M |
| December 31, 2019 | -159.43M |
| December 31, 2018 | -142.57M |
| December 31, 2017 | -120.59M |
| Date | Value |
|---|---|
| December 31, 2016 | -89.27M |
| December 31, 2015 | -73.48M |
| December 31, 2014 | -62.92M |
| December 31, 2013 | -52.45M |
| December 31, 2012 | -58.26M |
| December 31, 2011 | -44.86M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Annual) Range, Past 5 Years
-356.42M
Minimum
2022
-159.43M
Maximum
2019
-280.65M
Average
-282.09M
Median
2020
Net Income (Annual) Benchmarks
| AbbVie Inc | 4.863B |
| Design Therapeutics Inc | -66.86M |
| Humacyte Inc | -110.78M |
| Context Therapeutics Inc | -23.96M |
| AN2 Therapeutics Inc | -64.73M |